| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020812619 |
| P356 | DOI | 10.1038/SJ.GT.3302182 |
| P8608 | Fatcat ID | release_wj3e3pvxdbdl3cxbf6xwm75wgi |
| P698 | PubMed publication ID | 14973543 |
| P2093 | author name string | Joosten LA | |
| van den Berg WB | |||
| Varley AW | |||
| van Beuningen HM | |||
| Arntz OJ | |||
| Bakker AC | |||
| Bennink MB | |||
| de Hooge AS | |||
| Smeets RL | |||
| van de Loo FA | |||
| van der Kraan PK | |||
| P2860 | cites work | CpG methylation, chromatin structure and gene silencing-a three-way connection | Q24533302 |
| A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6 | Q24563031 | ||
| The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein | Q24680024 | ||
| Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency. | Q33919346 | ||
| Toll-like receptors: key mediators of microbe detection. | Q34493051 | ||
| Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators | Q34526913 | ||
| Endogenous regulation of a therapeutic transgene restores homeostasis in arthritic joints | Q34791340 | ||
| Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion | Q36400734 | ||
| Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors | Q36575731 | ||
| A 58-base-pair region of the human C3 gene confers synergistic inducibility by interleukin-1 and interleukin-6. | Q36773864 | ||
| Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB. | Q38296897 | ||
| Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung | Q39594251 | ||
| Functional and selective targeting of adenovirus to high-affinity Fcgamma receptor I-positive cells by using a bispecific hybrid adapter | Q39601286 | ||
| Molecular mechanisms of gene silencing mediated by DNA methylation | Q39674525 | ||
| Anti-TNF alpha monoclonal antibodies (infliximab) and tuberculosis: apropos of 3 cases | Q40585448 | ||
| Polymerase chain reaction for rapid diagnosis of respiratory adenovirus infection | Q40671571 | ||
| Phenotypic differences in murine chondrocyte cell lines derived from mature articular cartilage | Q40685849 | ||
| Comparative study and identification of potent eukaryotic transcriptional repressors in gene switch systems | Q40722269 | ||
| Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression | Q41074143 | ||
| A nitric oxide production bioassay for interferon-gamma | Q41151346 | ||
| Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. | Q41237683 | ||
| Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells | Q41516547 | ||
| Cis- and trans-acting elements required for constitutive and cytokine-regulated expression of the mouse complement C3 gene | Q41625429 | ||
| Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component | Q41839042 | ||
| Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee | Q42801221 | ||
| C3-Tat/HIV-regulated intraarticular human interleukin-1 receptor antagonist gene therapy results in efficient inhibition of collagen-induced arthritis superior to cytomegalovirus-regulated expression of the same transgene | Q43907092 | ||
| Inactivation of the very strong HCMV immediate early promoter by DNA CpG methylation in vitro | Q44644063 | ||
| Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist | Q45744151 | ||
| Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2activity | Q45864635 | ||
| Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells | Q45869823 | ||
| Demonstration of infectious DNA in transformed cells. III. Correlation of detection of infectious DNA-protein complexes with persistence of virus in simian adenovirus SA7-induced tumor cells | Q45883122 | ||
| A two-component expression system that responds to inflammatory stimuli in vivo | Q45883791 | ||
| Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver | Q45889223 | ||
| Physiologically responsive gene therapy | Q45889739 | ||
| Onset of multiple sclerosis associated with anti-TNF therapy | Q48704019 | ||
| Impaired immune and acute-phase responses in interleukin-6-deficient mice. | Q52514391 | ||
| Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production. | Q53966152 | ||
| Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation | Q61955148 | ||
| Effective treatment of established mouse collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express FasL | Q64378360 | ||
| Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4 | Q64380123 | ||
| Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis | Q71503443 | ||
| Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis | Q71750740 | ||
| Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis | Q72526685 | ||
| Synergistic activation of the human cytomegalovirus major immediate early promoter by prostaglandin E2 and cytokines | Q74148432 | ||
| Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis | Q77403524 | ||
| Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment | Q77844025 | ||
| Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product | Q78709124 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| inflammation | Q101991 | ||
| P304 | page(s) | 581-590 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | An inflammation-inducible adenoviral expression system for local treatment of the arthritic joint | |
| P478 | volume | 11 |
| Q92994177 | A Synthetic Gene Circuit for Self-Regulating Delivery of Biologic Drugs in Engineered Tissues |
| Q39450777 | A novel hybrid promoter responsive to pathophysiological and pharmacological regulation |
| Q42824694 | Application of a disease-regulated promoter is a safer mode of local IL-4 gene therapy for arthritis. |
| Q42084870 | Assembly PCR synthesis of optimally designed, compact, multi-responsive promoters suited to gene therapy application |
| Q37000837 | Cells of the synovium in rheumatoid arthritis. Chondrocytes |
| Q35834491 | Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimenta |
| Q33713191 | Computational design and application of endogenous promoters for transcriptionally targeted gene therapy for rheumatoid arthritis |
| Q34482730 | Disease-dependent local IL-10 production ameliorates collagen induced arthritis in mice |
| Q34169584 | Early gestational gene transfer of IL-10 by systemic administration of lentiviral vector can prevent arthritis in a murine model |
| Q38829316 | Efficient expression of bioactive murine IL12 as a self-processing P2A polypeptide driven by inflammation-regulated promoters in tumor cell lines. |
| Q59359723 | Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine Model |
| Q80448411 | Gene therapy for arthritis |
| Q35906093 | Gene therapy for autoimmune diseases: quo vadis? |
| Q36920198 | Gene therapy in The Netherlands: highlights from the Low Countries |
| Q24796801 | Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients? |
| Q37207021 | Gene therapy of the rheumatic diseases: 1998 to 2008. |
| Q36594242 | Gene therapy works in animal models of rheumatoid arthritis...so what! |
| Q30980638 | Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation |
| Q47697061 | Genome Engineering for Personalized Arthritis Therapeutics |
| Q42278257 | Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs |
| Q36512506 | IL10 released by a new inflammation-regulated lentiviral system efficiently attenuates zymosan-induced arthritis |
| Q40132461 | Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression |
| Q41036628 | Local delivery of beta interferon using an adeno-associated virus type 5 effectively inhibits adjuvant arthritis in rats |
| Q33713231 | Orthopedic gene therapy in 2008. |
| Q34543292 | PTHrP overexpression partially inhibits a mechanical strain-induced arthritic phenotype in chondrocytes |
| Q45859107 | Targeted gene therapy of autoimmune diseases: advances and prospects |
| Q36577437 | Technology insight: gene transfer and the design of novel treatments for rheumatoid arthritis. |
Search more.